Stock Research: Medacta Group

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Medacta Group

SWX:MOVE CH0468525222
78
  • Value
    8
  • Growth
    96
  • Safety
    Safety
    70
  • Combined
    70
  • Sentiment
    70
  • 360° View
    360° View
    78
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Medacta Group SA is a Swiss-based medical device company specializing in orthopedic products and surgical techniques. The company operates in joint replacement, spine surgery, and sports medicine, offering hip, knee, shoulder, and spine products. It operates globally, providing training and support to healthcare professionals. In the last fiscal year, the company had a market cap of $3419 million, profits of $414 million, revenue of $611 million, and 1907 employees.

more

ANALYSIS: With an Obermatt 360° View of 78 (better than 78% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Medacta Group are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Medacta Group. The consolidated Growth Rank has a good rank of 96, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 96% of competitors in the same industry. The consolidated Safety Rank at 70 means that the company has a financing structure that is safer than 70% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 70, which means that professional investors are more optimistic about the stock than for 70% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 8, meaning that the share price of Medacta Group is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 92% of alternative stocks in the same industry. ...read more

more
Index
SPI
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 20 13 41
Growth
96 80 99 71
Safety
Safety
70 41 39 37
Sentiment
70 78 77 32
360° View
360° View
78 54 73 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
74 69 46 19
Opinions Change
50 84 79 92
Pro Holdings
n/a 65 59 47
Market Pulse
76 57 68 12
Sentiment
70 78 77 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 20 13 41
Growth
96 80 99 71
Safety Safety
70 41 39 37
Combined
70 45 52 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
11 15 16 31
Price vs. Earnings (P/E)
13 21 21 44
Price vs. Book (P/B)
12 6 1 14
Dividend Yield
34 44 43 49
Value
8 20 13 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
94 85 75 65
Profit Growth
45 81 91 64
Capital Growth
77 37 56 45
Stock Returns
76 62 91 69
Growth
96 80 99 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
45 39 40 26
Refinancing
64 34 31 33
Liquidity
77 75 56 52
Safety Safety
70 41 39 37

Similar Stocks

Discover high‑ranked alternatives to Medacta Group and broaden your portfolio horizons.

Swatch

VTX:UHR
Country: Switzerland
Industry: Apparel, Accessories, Luxury
Size: X-Large
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Alcon

VTX:ALC
Country: Switzerland
Industry: Health Care Supplies
Size: X-Large
Full Stock Analysis

DKSH

SWX:DKSH
Country: Switzerland
Industry: Trading & Distribution
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: